Inventor

ZEPPEZAUER MICHAEL

DE12 patents

⚠️ This page may combine multiple inventors who share the name “ZEPPEZAUER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RUSCH VOLKER

2 patents

US4818763AApr 4, 1989

Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes

RUSCH VOLKER25 citations88

US5182257AJan 26, 1993

Use of pure histones h1 and h2a:h2b dimers in therapeutic methods

RUSCH VOLKER22 citations87

ZEPPEZAUER MICHAEL

2 patents

US7902146B2Mar 8, 2011

Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties

ZEPPEZAUER MICHAEL5 citations53

US8778875B2Jul 15, 2014

Use of an active biological substance in abnormal cellular and viral membrane physiologies

ZEPPEZAUER MICHAEL0 citations48

SYMBIOTEC GENELLSCHAFT ZUR ERFORSCHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBH

2 patents

US9796767B2Oct 24, 2017

Bis-met histones

SYMBIOTEC GENELLSCHAFT ZUR ERFORSCHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBH0 citations44

US9790259B2Oct 17, 2017

Bis-Met histones

SYMBIOTEC GENELLSCHAFT ZUR ERFORSCHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBH0 citations44

PHILADELPHIA HEALTH & EDUCATIO

1 patent

US6884423B1Apr 26, 2005

Antimicrobial histone H1 compositions, kits, and methods of use thereof

PHILADELPHIA HEALTH & EDUCATIO11 citations70

ALLEGHENY UNIVERSITY OF THE HE

1 patent

US5780432AJul 14, 1998

Therapeutic method for treatment of carcinoma or autoimmune diseases

ALLEGHENY UNIVERSITY OF THE HE10 citations70

GROSS PETER

1 patent

US9409960B2Aug 9, 2016

Bis-met histones

GROSS PETER4 citations68

SYMBIOTEC GMBH

1 patent

US5578571ANov 26, 1996

Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures

SYMBIOTEC GMBH10 citations61

SYMBIOTEC GES ZUR ERFORSCHUNG

1 patent

US6369203B1Apr 9, 2002

Peptides for the production of preparations for the diagnosis and therapy of systemic lupus

SYMBIOTEC GES ZUR ERFORSCHUNG4 citations45

SYMBIOTEC GENELLSCHAFT ZUR ERFORSHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBH

1 patent

US8962562B2Feb 24, 2015

Use of histones for therapeutic purposes

SYMBIOTEC GENELLSCHAFT ZUR ERFORSHUNG AUF DEM GEIBEIT DER BIOTECHNOLOGIE MBH1 citations43